DALLAS--(BUSINESS WIRE)--Generational Group, a leading mergers and acquisitions advisory firm for privately held businesses, is pleased to announce the sale of Delta Waves, Inc. to Doctors, Inc. The acquisition closed December 9, 2025. Headquartered in...
Seasoned healthcare and technology leader brings deep expertise in AI-powered, consumer-driven digital health experiencesSAN FRANCISCO--(BUSINESS WIRE)--#HealthWayFinding--Transcarent, the first agentic AI-powered health and care platform, today annou...
Allows for Commercial Deployment of the Company’s Radiation-Free Breast Imaging Technology Under Distribution Agreement with Gulf Medical Co.NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a me...
AI-powered pre-screening infrastructure enables scalable, privacy-preserving clinical trial matching across underserved patient populations in the Atlanta region.BOCA RATON, Fla.--(BUSINESS WIRE)--Massive Bio, a leader in AI-enabled patient recruitmen...
Kordata Dynamics has launched a new model of precision clinical trials, with an AI platform powered by BIOS Health, designed to improve quality, speed, and accessibility throughout the healthcare systems. The announcement came in the same week the F...
Eligible Canadians can now access Health Canada–approved generic semaglutide directly, by prescription, starting at $124.99TORONTO--(BUSINESS WIRE)--Today, Phoenix and Raven, leading Canadian digital health providers, announced the launch of generic s...
Formation of DelivMeds AI, Inc. (ticker reserved: NASDAQ:MEDS), with an expected approximate combined asset value of $4 billion, is subject to an independent fairness opinion. Fully binding term sheet between Datavault AI (NASDAQ:DVLT) and Wellgistic...
SAARBRÜCKEN, Germany--(BUSINESS WIRE)--New peer-reviewed research published by ki:elements and the PROSPECT-AD consortium demonstrates that the company’s Speech Biomarker for Cognition (SB-C) can reliably detect cognitive impairment and signal underlyi...
EndoTool IV Cloud is the first FDA-cleared, cloud-based patient-specific insulin dosing platform, designed to support scalable deployment Commercial launch anticipated before the end of 2026PALO ALTO, Calif.--(BUSINESS WIRE)--Glooko, Inc., a global di...
NEW YORK--(BUSINESS WIRE)--Galloway Capital Partners, LLC (“Galloway”), together with its affiliates, today announced that it has accumulated an ownership stake of approximately 8.42% in WW International, Inc. (“WW” or the “Company”). Galloway believes...